Literature DB >> 21427388

Inappropriate tuberculosis treatment regimens in Chinese tuberculosis hospitals.

Guang Xue He1, Susan van den Hof, Marieke J van der Werf, Hui Guo, Yuan Lian Hu, Ji Huan Fan, Wei Min Zhang, Christopher P Tostado, Martien W Borgdorff.   

Abstract

This investigation of tuberculosis (TB) treatment regimens in 6 TB hospitals in China showed that only 18% of patients with new cases and 9% of patients with retreatment cases were prescribed standard TB treatment regimens. Adherence to treatment guidelines needs to be improved in TB hospitals to control multidrug-resistant TB in China.
© The Author 2011. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21427388     DOI： 10.1093/cid/cir075

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  14 in total

Review 1.  Recent transmission of Mycobacterium tuberculosis in China: the implication of molecular epidemiology for tuberculosis control.

Authors:  Chongguang Yang; Qian Gao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

2.  Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation.

Authors:  Chongguang Yang; Tao Luo; Xin Shen; Jie Wu; Mingyu Gan; Peng Xu; Zheyuan Wu; Senlin Lin; Jiyun Tian; Qingyun Liu; ZhengAn Yuan; Jian Mei; Kathryn DeRiemer; Qian Gao
Journal:  Lancet Infect Dis       Date:  2016-12-03       Impact factor: 25.071

3.  Tuberculosis control strategies to reach the 2035 global targets in China: the role of changing demographics and reactivation disease.

Authors:  Grace H Huynh; Daniel J Klein; Daniel P Chin; Bradley G Wagner; Philip A Eckhoff; Renzhong Liu; Lixia Wang
Journal:  BMC Med       Date:  2015-04-21       Impact factor: 8.775

4.  Access to Bacteriologic-Based Diagnosis in Smear Positive Retreatment Tuberculosis Patients in Rural China: A Cross-Sectional Study in Three Geographic Varied Provinces.

Authors:  Changming Zhou; Weili Jiang; Li Yuan; Wei Lu; Jinge He; Qi Zhao; Biao Xu
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

5.  Better care provided to patients with tuberculosis at county designated TB hospitals (CTD) compared to non-CTDs in rural China.

Authors:  Li Yuan; Hui Zhang; Changming Zhou; Weili Jiang; Qi Zhao; Xu Biao
Journal:  BMC Infect Dis       Date:  2017-01-13       Impact factor: 3.090

6.  Comparison of medicines management strategies in insurance schemes in middle-income countries: four case studies.

Authors:  Warren A Kaplan; Paul G Ashigbie; Mohamad I Brooks; Veronika J Wirtz
Journal:  J Pharm Policy Pract       Date:  2017-05-16

7.  Prescription practice of anti-tuberculosis drugs in Yunnan, China: A clinical audit.

Authors:  Lin Xu; Jinou Chen; Anh L Innes; Ling Li; Chen-Yuan Chiang
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

8.  Implementing a "free" tuberculosis (TB) care policy under the integrated model in Jiangsu, China: practices and costs in the real world.

Authors:  Xinxin Jia; Jiaying Chen; Siyuan Zhang; Bing Dai; Qian Long; Shenglan Tang
Journal:  Infect Dis Poverty       Date:  2016-01-22       Impact factor: 4.520

9.  High-risk screening and detection of multidrug-resistant tuberculosis in two prefectures of China: a drug susceptibility surveillance-based secondary data analysis.

Authors:  Zhiqi Yang; Changming Zhou; Zhu Ning; Wei Lu; Qi Zhao; Yi Hu; Vinod K Diwan; Biao Xu
Journal:  Glob Health Action       Date:  2018       Impact factor: 2.640

10.  Factors Influencing Hospitalization Rates and Inpatient Cost of Patients with Tuberculosis in Jiangsu Province, China: An Uncontrolled before and after Study.

Authors:  Dan Hu; Qian Long; Jiaying Chen; Xuanxuan Wang; Fei Huang; John S Ji
Journal:  Int J Environ Res Public Health       Date:  2019-08-01       Impact factor: 3.390
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.